Press release
Chemotherapy-induced Nausea and Vomiting Drugs Market 2017
According to the report, the high unmet medical need in the market has driven the R&D activities of existing as well as new vendors. Helsinn is one of the leading companies that has a strong pipeline of CINV drugs with two drug candidates in Phase III and Phase I stages. Helsinn has collaborated with Taiho Pharmaceutical for the development and commercialization of netupitant IV in Japan. Heron Therapeutics is developing HTX-019, currently in Phase I stage, for the prevention and treatment of CINV. In addition, new vendors such as Shin Nippon Biomedical Laboratories and Acacia Pharma are aggressively advancing their pipeline to launch new drugs during the forecast period. Shin Nippon Biomedical Laboratories and Acacia are developing granisetron intranasal and APD403, respectively. Both these drugs are in Phase II development stage. These pipeline drugs are expected to gain approval during the forecast period and will likely fuel the market growth.
Download Sample Report @ https://marketreportscenter.com/request-sample/494138
Covered in this report
The report covers the present scenario and the growth prospects of the global CINV drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of CINV drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck
Tesaro
Other prominent vendors
Acacia Pharma
Aphios
Baxter Healthcare
Dr. Reddy's Laboratories
Eisai
Especificos Stendhal
F. Hoffmann-La Roche
Kyowa Hakko Kirin
ees Pharmaceutical Holdings
Midatech Pharma
Mundipharma
Mylan
Ono Pharmaceutical
OPKO Health
Orchid Chemicals & Pharmaceuticals
Otsuka Pharmaceutical
Purdue Pharma
Sandoz (a subsidiary of Novartis)
SciClone Pharmaceuticals
Shin Nippon Biomedical Laboratories
Solasia Pharma K.K.
Specialised Therapeutics
Sun Pharma
Taiho Pharmaceutical
Teva Pharmaceuticals
Market driver
Growing preference of chemotherapy drugs in developing countries
For a full, detailed list, view our report
Market challenge
Growing popularity of alternate therapies for the treatment of cancer in developed countries
For a full, detailed list, view our report
Market trend
Increasing inorganic growth strategies likely to fuel the market growth
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://marketreportscenter.com/reports/494138/global-chemotherapy-induced-nausea-and-vomiting-drugs-market-2017-2021
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Highlights
PART 05: Disease overview
Understanding the disease
Pathophysiology
Central pathway
Peripheral pathway
Management of disease
PART 06: Pipeline analysis
PART 07: Market landscape
Global CINV drugs market
Five forces analysis
PART 08: Market segmentation by therapy
Serotonin receptor antagonists
NK1 receptor antoagonists
Others
PART 09: Geographical segmentation
CINV drugs market in Americas
CINV drugs market in EMEA
CINV drugs market in APAC
PART 10: Market drivers
Growing cancer population driving the market growth
Growing preference for chemotherapy drugs in developing countries
Approval of new drugs fuels the market growth
PART 11: Impact of drivers
PART 12: Market challenges
……..CONTINUED
Check Discount On This Report @ https://marketreportscenter.com/request-discount/494138
For more information, please visit https://marketreportscenter.com
For more information content with us;
Sam Collins
Market Reports Center 1-646-883-3044 (US)
info@marketreportscenter.com
https://marketreportscenter.com
Source: https://marketreportscenter.com/reports/494138/global-chemotherapy-induced-nausea-and-vomiting-drugs-market-2017-2021
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. Market Reports Center’s team consistently works to update and extend our existing repository of market research reports by partnering with new publishers and adding their studies to our website.
Sam Collins
303, Astral Court,
Aundh, Pune,
MH - 411045, India
info@marketreportscenter.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy-induced Nausea and Vomiting Drugs Market 2017 here
News-ID: 463374 • Views: …
More Releases from MRC Pharmaceutical Reports
Robotic Pharmacy Prescription Dispensing Systems Market 2017: BD, Omnicell, Pa …
Market Research analysts forecast the global robotic pharmacy prescription systems market to grow at a CAGR of 5.16% during the period 2017-2021.
According to the report, the automation of prescription dispensing is becoming increasingly essential because of the deficit in the quality staff in pharmacies. This has led to increased adoption of pharmacy automation systems to reduce dispensing errors, improvement in the dispensing process, optimization of space utilization in pharmacies, and…
Pharmaceutical Excipients Market Size, Share, Trends, Analysis and Forecasts To …
Market Research analysts forecast the global pharmaceutical excipients market to grow at a CAGR of 6.53% during the period 2017-2021.
The following companies as the key players in the global pharmaceutical excipients market: ADM, Ashland, BASF, Evonik Industries, and Dow Chemical.
Other Prominent Vendors in the market are: Associated British Foods, FMC, Lubrizol, and Roquette Pharma.
Commenting on the report, an analyst team said: The latest trend gaining momentum in the market is…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
